In a new study published June 20 in Nature Biomedical Engineering, researchers at Yale School of Medicine and collaborators took a significant step toward understanding idiopathic pulmonary ...

The delay leaves millions of rural Americans stranded in places where health care is hard to access and telehealth is out of reach.

A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of HIV.